Atomwise

Atomwise employs artificial intelligence for drug discovery by designing new molecules aimed at the most challenging targets. The AI-enabled discovery portfolio includes wholly owned and co-developed pipeline assets, supported by notable investors. This innovative approach seeks to deliver better medicines faster for partners in the health and pharmaceutical sectors.
Header image